Explorer les evidences

35,4 scoreThe post-intervention overall symptom domain score was 35.4 ± 12.4 for the control group.

Nigeriacancer du seinpublié 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 8 observations

41 %Among 436 treatment-naïve Nigerian breast cancer patients, 41% were classified as having intermediate tumor-infiltrating lymphocytes (TILs) (10–<40%).

Nigeriacancer du seinpublié 2026Breast cancer research and treatmentPubMeddocument de 14 observations

20,17 %Africans had the lowest rs1799966 C allele frequency at 20.17%.

Nigeriacancer du seinpublié 2026Cancer control : journal of the Moffitt Cancer CenterPubMeddocument de 7 observations

64 %64% of patients experienced advanced-stage diagnosis after early breast cancer detection.

Nigeriacancer du seinpublié 2021PloS onePubMeddocument de 6 observations

1,47 aORWomen with a self-reported history of benign breast disease had greater odds of developing breast cancer than those without, with an adjusted odds ratio of 1.47 (95% CI 1.13–1.91).

Nigeriabenign breast disease · cancer du seinpublié 2024Cancer causes & control : CCCPubMeddocument de 5 observations

35,3 %Among breast cancer patients undergoing chemotherapy in Delta State, Nigeria, 35.3% had severe or very severe symptom burden.

Nigeriacancer du seinpublié 2026The Pan African medical journalPubMeddocument de 5 observations

42,8 %In the MEND case-control study, 42.8% of Nigerian breast cancer cases were triple-negative breast cancer (TNBC).

Nigeriacancer du sein · cancer du sein triple-négatifpublié 2026Breast cancer research and treatmentPubMeddocument de 10 observations

81,3 %Breast cancer awareness was 81.3% at baseline in three randomly-selected schools in Southeast Nigeria.

Nigeriacancer du seinpublié 2025Journal of health, population, and nutritionPubMeddocument de 6 observations

38,25 %Asians showed the highest rs1799966 C allele frequency at 38.25%.

Nigeriacancer du seinpublié 2026Cancer control : journal of the Moffitt Cancer CenterPubMeddocument de 7 observations

78,6 %Survival for early-stage (I and II) breast cancer was 78.6%, compared to 33.3% for late-stage (III or IV) disease among patients in Nigeria between January 2010 and December 2018.

Nigeriacancer du seinobservé 2010–2018publié 2021International journal of cancerPubMeddocument de 12 observations

28 %Among 352 breast cancer patients, 28% were stage 3.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

98,8 %Eighty-one (98.8%) of the 82 breast cancer patients were females.

Nigeriacancer du seinobservé 2011–2015publié 2020The Pan African medical journalPubMeddocument de 16 observations

62,2 %Fifty-one (62.2%) of the 82 breast cancer patients had mastectomy.

Nigeriacancer du seinobservé 2011–2015publié 2020The Pan African medical journalPubMeddocument de 16 observations

7,1 %Nigerian breast cancer patients have a BRCA1 mutation frequency of 7.1%.

Nigeriacancer du seinpublié 2012International journal of cancereurope_pmcdocument de 2 observations

454 patientsThere were 454 breast cancer patients in the institutional database during 2019–2022.

Nigeriacancer du seinobservé 2019-2022publié 2023West African journal of medicinePubMeddocument de 8 observations

49 yearsThe median age of the breast cancer patient cohort was 49 years.

Nigeriacancer du seinobservé May 2009–January 2019publié 2021CancerPubMeddocument de 7 observations

75 %75% of the respondents had not accompanied their wife/female partner for breast cancer screening.

Nigeriacancer du seinobservé 2018publié 2023PloS onePubMeddocument de 14 observations

2 %2% of the tumors were luminal B.

Nigeriacancer du seinpublié 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 12 observationsDOI 10.1200/jco.2008.19.6873

65,06 %216 (65.06%) of the respondents reported they have had a mammogram.

Nigeriacancer du seinpublié 2020West African journal of medicinePubMeddocument de 6 observations

34,03 %34.03% of the respondents had a low level of perceived risk of breast cancer.

Nigeriacancer du seinpublié 2023BMC women's healthPubMeddocument de 12 observations

Breast cancer is the most diagnosed female malignancy in Nigeria.

Nigeriacancer du seinpublié 2022African health sciencesPubMeddocument de 5 observations

0,36 aORStable high life-course education relative to father was associated with a significantly lower likelihood of having high-grade breast cancer (adjusted odds ratio 0.36; 95% confidence interval 0.15 to 0.87) compared to stable low life-course education.

Nigeriacancer du seinpublié 2021Annals of global healthPubMeddocument de 7 observations

100 %All 82 breast cancer patients routinely took tamoxifen.

Nigeriacancer du seinobservé 2011–2015publié 2020The Pan African medical journalPubMeddocument de 16 observations

39,4 %Oestrogen receptor positivity was 39.4%.

Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 13 observations

74,38 %74.38% of the participants had been diagnosed with breast cancer for 3 years or more.

Nigeriacancer du seinpublié 2024Nigerian journal of clinical practicePubMeddocument de 5 observations